Evista vs Raloxifene: are they the same?
Evista is a commercial brand whose active ingredient is exactly Raloxifene. This page explains what that means in practice: where they differ (brand, manufacturer, price, available strengths), why they are clinically equivalent, and when the brand or an authorised generic is the better choice.
Are they the same?
Yes — Evista contains Raloxifene as its active ingredient. Talking about "Evista" in clinical terms is the same as talking about Raloxifene at the dose strengths 60mg. The differences from the authorised generic are brand, manufacturer (Eli Lilly), excipients, tablet appearance and price — not the active molecule itself.
When Evista is used
에비스타는 폐경후 골다공증의 예방 및 치료와 위험이 증가된 폐경후 여성에서 침습성 유방암 위험 감소에 승인되어 있습니다. 현행 골다공증 가이드라인에 따르면 랄록시펜은 유방암 위험이 높은 폐경후 골다공증 여성에서 합리적 선택지이지만, 비척추 골절 감소가 더 큰 비스포스포네이트가 대부분의 환자에서 1차 선택약으로 남아 있습니다.
Mechanisms compared
Because they share the same active ingredient, the mechanism is identical: 랄록시펜은 에스트로겐 수용체에 결합하여 조직 선택적 효과를 나타냅니다.
Brand or generic — which to choose?
For most patients, authorised generics of Raloxifene are clinically equivalent substitutes for Evista and typically cost substantially less. The practical differences are manufacturer, excipients (rarely matters except in specific sensitivities), tablet appearance and price. The brand is preferred by some patients for personal reasons or insurance coverage; the generic is the default when cost matters.
자주 묻는 질문
Is Evista the same as Raloxifene? ▾
Clinically yes — Evista is the brand and Raloxifene is its active ingredient. At equivalent doses (60mg) they produce the same effect. The difference is brand, manufacturer (Eli Lilly) and price.
Is generic Raloxifene as effective as Evista? ▾
Yes. Authorised generics of Raloxifene must demonstrate bioequivalence to the brand. The active substance is the same; average effect is the same. Price is usually substantially lower.
Why does Evista cost more than generic Raloxifene? ▾
The price difference reflects originator development costs, brand recognition and competition among generic manufacturers. The molecule is identical; the cost is not.
본 웹사이트의 정보는 참고 및 교육 목적으로만 제공됩니다. 자격을 갖춘 의료 전문가의 상담을 대체하지 않습니다.